Winchester, MA, United States of America

Ales Medek

This inventor holds 24 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Vertex Pharmaceuticals, Inc., Alios Biopharma, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ales Medek. Retrieved from https://idiyas.com/inventor/ales-medek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 24)

% Patents Active = 87.5

CIPO Patents = 3 (Patent Applications = 14)

EPO Patents = 7 (Patent Applications = 30)

Average Co-Inventor Count = 10.3

ph-index = 8

Forward Citations = 443(Granted Patents)

Company Filing History:

22 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

2 out of 44

Alios Biopharma, Inc.

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

APOL1 Inhibitors

Alpha-1 Antitrypsin Modulators

CFTR Modulators

Pharmaceutical Compositions

Cystic Fibrosis

ATR Kinase Inhibitors

Solid Forms

Nucleotide Prodrugs

Influenza Virus Inhibitors

Crystalline Forms

Co-crystals

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612379 - Inhibitors of APOL1 and methods of using same (2026-04-28),

2. 12577233 - Solid forms of APOL1 inhibitor and methods of using same (2026-03-17),

3. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

4. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),

5. 12060346 - Inhibitors of APOL1 and methods of using same (2024-08-13),

6. 11951212 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases (2024-04-09),

7. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

8. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),

9. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

10. 11618746 - Inhibitors of APOL1 and methods of using same (2023-04-04),

11. 11485739 - Compounds useful as inhibitors of ATR kinase (2022-11-01),

12. 10980746 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases (2021-04-20),

13. 10815239 - Compounds useful as inhibitors of ATR kinase (2020-10-27),

14. 10206877 - Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases (2019-02-19),

15. 10160760 - Compounds useful as inhibitors of ATR kinase (2018-12-25),

Title: The Innovative Journey of Ales Medek

Introduction:

Ales Medek, a talented inventor based in Winchester, MA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

Ales Medek holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights:

Throughout his career, Ales Medek has worked with top research institutions and leading companies to bring his inventions to life. His dedication to pushing the boundaries of technology has led to the development of cutting-edge solutions that have positively impacted various industries.

Collaborations:

Ales Medek has collaborated with renowned scientists, engineers, and experts in the field to further enhance his inventions and ensure their successful implementation in real-world applications. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Ales Medek's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire the next generation of innovators to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.